<DOC>
	<DOCNO>NCT02135393</DOCNO>
	<brief_summary>The aim study test assumption , human , folic acid , dietary supplement biotransformed ( reduce methylated ) natural circulate plasma folate 6S-5Methyltetrahydrofolic acid ( 5-MTHF ) intestinal mucosa .</brief_summary>
	<brief_title>Where Initial Site Biotransformation Folates Humans ?</brief_title>
	<detailed_description>Current thinking , base mainly rodent study , physiological dos folic acid ( pteroylmonoglutamic acid ) , like dietary vitamin folate , biotransformed intestinal mucosa transfer portal vein natural circulate plasma folate , 5-methyltetrahydrofolic acid ( 5-MTHF ) , enter liver wide systemic blood supply . Study design : Open label study sample portal peripheral vein label folate concentration follow oral ingestion physiological dos dietary supplement stable-isotope-labelled folic acid , , reduce folate , 5-formyltetrahydrofolic acid ( 5-FormylTHF ) . The study perform subject Transjugular Intrahepatic Porto Systemic Shunt ( TIPSS ) situ time routine annual patency check allow blood sample take portal vein . The aim study test assumption , human , folic acid biotransformed ( reduce methylated ) 5-MTHF intestinal mucosa .</detailed_description>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Stable , synthetic liver function without recent evidence decompensation ( define liver function inadequacy active complication portal hypertension ) Abstinent alcohol Free malignant disease Normal gut permeability ( assessed lactulose/mannitol test ) Patent TIPSS last surveillance Taking Vitamin B supplement Taking Folic Acid supplementation Unable provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>